MD Anderson researcher Aggarwal loses paper in Cancer Letters
Whether it’s a one-off or a sign of things to come, Bharat Aggarwal, the MD Anderson scientist at the center of a blogospheric storm—and an institutional investigation—over the validity of his data, has had a paper withdrawn by the journal Cancer Letters.The article,”Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand,” was published in December. According to the notice:
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.
What’s not clear is why, of course. Aggarwal, who recently acknowledged to Retraction Watch that MD Anderson was investigating his laboratory, refused to discuss the reason for the withdrawal of the article. The paper is among a slew of Aggarwal’s articles that have been flagged as suspect by Abnormal Science and others.
Hat tip: Virgilstar